These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling. Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279 [TBL] [Abstract][Full Text] [Related]
4. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615 [TBL] [Abstract][Full Text] [Related]
5. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855 [TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1. Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211 [TBL] [Abstract][Full Text] [Related]
7. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice. Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506 [TBL] [Abstract][Full Text] [Related]
8. Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling. Chen Y; Wang B; Ou X; Wu Y; He Y; Lin X; Lin X J Virol; 2022 Dec; 96(23):e0102022. PubMed ID: 36394315 [TBL] [Abstract][Full Text] [Related]
9. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis. Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427 [TBL] [Abstract][Full Text] [Related]
10. NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Sheng L; Zhou Y; Chen Z; Ren D; Cho KW; Jiang L; Shen H; Sasaki Y; Rui L Nat Med; 2012 Jun; 18(6):943-9. PubMed ID: 22581287 [TBL] [Abstract][Full Text] [Related]
11. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis. Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity. Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770 [TBL] [Abstract][Full Text] [Related]
13. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis. Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929 [TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan from Apostichopus japonicus inhibits hepatic glucose production via activating Akt/FoxO1 and inhibiting PKA/CREB signaling pathways in insulin resistant hepatocytes. Chen Y; Liu H; Wang Y; Yang S; Yu M; Jiang T; Lv Z Food Funct; 2019 Nov; 10(11):7565-7575. PubMed ID: 31687719 [TBL] [Abstract][Full Text] [Related]
15. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB). Xiao F; Deng J; Jiao F; Hu X; Jiang H; Yuan F; Chen S; Niu Y; Jiang X; Guo F FASEB J; 2022 Oct; 36(10):e22541. PubMed ID: 36083102 [TBL] [Abstract][Full Text] [Related]
16. Progesterone increases blood glucose via hepatic progesterone receptor membrane component 1 under limited or impaired action of insulin. Lee SR; Choi WY; Heo JH; Huh J; Kim G; Lee KP; Kwun HJ; Shin HJ; Baek IJ; Hong EJ Sci Rep; 2020 Oct; 10(1):16316. PubMed ID: 33005004 [TBL] [Abstract][Full Text] [Related]
17. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis. Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215 [TBL] [Abstract][Full Text] [Related]
18. HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling. Ramakrishnan SK; Zhang H; Takahashi S; Centofanti B; Periyasamy S; Weisz K; Chen Z; Uhler MD; Rui L; Gonzalez FJ; Shah YM Cell Metab; 2016 Mar; 23(3):505-16. PubMed ID: 26853750 [TBL] [Abstract][Full Text] [Related]
19. NFIL3 is a negative regulator of hepatic gluconeogenesis. Kang G; Han HS; Koo SH Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537 [TBL] [Abstract][Full Text] [Related]
20. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity. Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]